Mike Waters is the General Manager at Recordati Rare Diseases, where he is responsible for building and managing the company’s stand-alone U.S. business. Prior to joining Recordati Rare Diseases, he spent six years at Lundbeck. As Vice President of Operations, he played a vital role in U.S. Chemistry, Manufacturing and Controls (CMC) development, launch, and lifecycle plans. He also served as the Vice President of Operations for Ovation Pharmaceuticals, supporting activities that were instrumental in the sale of the company to Lundbeck in 2009. He also held roles at Chiron Corp. as Senior Vice President of Technology Development and Operations and at Johnson & Johnson’s Ortho-McNeil Pharmaceuticals as Director of Business Development.
Mr. Waters received his B.S. in Pharmacy with honors from the University of Louisiana at Monroe. He went on to earn his M.E. in Biomedical Engineering from the University of Virginia.